GFACX
Price
$74.83
Change
+$0.34 (+0.46%)
Updated
Sep 29 closing price
Net Assets
336.88B
PRECX
Price
$19.86
Change
+$0.03 (+0.15%)
Updated
Sep 29 closing price
Net Assets
1.09B
Interact to see
Advertisement

GFACX vs PRECX

Header iconGFACX vs PRECX Comparison
Open Charts GFACX vs PRECXBanner chart's image
American Funds Growth Fund of Amer C
Price$74.83
Change+$0.34 (+0.46%)
VolumeN/A
Net Assets336.88B
PGIM Jennison Blend C
Price$19.86
Change+$0.03 (+0.15%)
VolumeN/A
Net Assets1.09B
GFACX vs PRECX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
GFACX vs. PRECX commentary
Sep 30, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GFACX is a Hold and PRECX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
GFACX has more cash in the bank: 337B vs. PRECX (1.09B). GFACX (0.00) and PRECX (0.00) have matching dividends . GFACX was incepted earlier than PRECX: GFACX (25 years) vs PRECX (31 years). PRECX (1.89) is less costly to investors than GFACX (1.36). PRECX is a more actively managed with annual turnover of: 47.00 vs. GFACX (25.00). GFACX has a lower initial minimum investment than PRECX: GFACX (250) vs PRECX (1000). GFACX annual gain was more profitable for investors over the last year : 10.95 vs. PRECX (-4.62). GFACX return over 5 years is better than : 35.26 vs. PRECX (4.70).
GFACXPRECXGFACX / PRECX
Total Expense Ratio1.361.8972%
Annual Report Gross Expense Ratio1.361.8972%
Fund Existence25 years31 years-
Gain YTD16.8297.538223%
Front LoadN/AN/A-
Min. Initial Investment250100025%
Min. Initial Investment IRAN/AN/A-
Net Assets337B1.09B30,861%
Annual Yield % from dividends0.000.00-
Returns for 1 year10.95-4.62-237%
Returns for 3 years67.3241.14164%
Returns for 5 years35.264.70750%
Returns for 10 years85.815.871,461%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
RKDA3.440.04
+1.03%
Arcadia Biosciences
EQV10.39N/A
N/A
EQV Ventures Acquisition Corp
SWKS76.93-2.58
-3.24%
Skyworks Solutions
COEP16.51-0.99
-5.66%
Coeptis Therapeutics Holdings Inc
NN14.78-0.95
-6.04%
NextNav